Analysts at StockNews.com initiated coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research note issued on ...

Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alpha Teknova (TKNO – Research Report), Wave Life Sciences ...

NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...

Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss of 15 cents. The Zacks Consensus Estimate is pegged at a loss per ...

Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its fourth-quarter and full-year 2024 ...

After hours: March 10 at 4:02:14 PM EDT Loading Chart for NVRO ...

March S&P 500 E-Mini futures (ESH25) are down -0.49%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.63% this morning, pointing to further losses on Wall Street as concerns over global trade ...

After hours: March 7 at 6:00:01 p.m. EST Loading Chart for NVRO ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

After hours: March 7 at 5:17:32 p.m. EST Loading Chart for GMED ...